These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 7684581)

  • 1. Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
    Tokunaga M; Mita S; Sakuta R; Nonaka I; Araki S
    Ann Neurol; 1993 Mar; 33(3):275-80. PubMed ID: 7684581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single muscle fiber analysis of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
    Tokunaga M; Mita S; Murakami T; Kumamoto T; Uchino M; Nonaka I; Ando M
    Ann Neurol; 1994 Apr; 35(4):413-9. PubMed ID: 8154867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA and RNA processing in MELAS.
    Kaufmann P; Koga Y; Shanske S; Hirano M; DiMauro S; King MP; Schon EA
    Ann Neurol; 1996 Aug; 40(2):172-80. PubMed ID: 8773598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of PDCD5 and other apoptosis-related proteins in muscle of patients with mitochondrial cytopathy].
    Li YF; Wang ZX; Gao XG; Hong DJ; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1593-6. PubMed ID: 19957502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mitochondrial myopathy, deafness and type 2 diabetes mellitus with tRNALeu(UUR) point mutation in mitochondrial DNA].
    Stratilová L; Zeman J; Hansíková H; Houstĕk J; Hermanská J; Dudková Z; Konrádová V; Hůlková H; Elleder M
    Cas Lek Cesk; 1998 Jul; 137(14):430-3. PubMed ID: 9748738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic heterogeneity in a Chinese family with mitochondrial disease and A3243G mutation of mitochondrial DNA.
    Thajeb P; Lee HC; Pang CY; Jeng CM; Huang SF; Wei YH
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):71-6. PubMed ID: 10645055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An infant with a mitochondrial A3243G mutation demonstrating the MELAS phenotype.
    Kanaumi T; Hirose S; Goto Y; Naitou E; Mitsudome A
    Pediatr Neurol; 2006 Mar; 34(3):235-8. PubMed ID: 16504796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated cytochrome c oxidase deficiency as a cause of MELAS.
    Rossmanith W; Freilinger M; Roka J; Raffelsberger T; Moser-Thier K; Prayer D; Bernert G; Bittner RE
    J Med Genet; 2008 Feb; 45(2):117-21. PubMed ID: 18245391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial diseases.
    Nonaka I
    Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):622-32. PubMed ID: 1392136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation.
    Auré K; Fayet G; Leroy JP; Lacène E; Romero NB; Lombès A
    Brain; 2006 May; 129(Pt 5):1249-59. PubMed ID: 16537564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies.
    Hess JF; Parisi MA; Bennett JL; Clayton DA
    Nature; 1991 May; 351(6323):236-9. PubMed ID: 1755869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vascular pathology in chronic progressive external ophthalmoplegia with ragged-red fibers].
    Hasegawa H; Matsuoka T; Goto Y; Nonaka I
    Rinsho Shinkeigaku; 1992 Feb; 32(2):155-60. PubMed ID: 1611773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype.
    Melone MA; Tessa A; Petrini S; Lus G; Sampaolo S; di Fede G; Santorelli FM; Cotrufo R
    Arch Neurol; 2004 Feb; 61(2):269-72. PubMed ID: 14967777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["MELAS" (A3243G) mutation of mitochondrial DNA: a study of the relationships between the clinical phenotype in 19 patients and morphological and molecular data].
    Laforêt P; Ziegler F; Sternberg D; Rouche A; Frachon P; Fardeau M; Eymard B; Lombès A
    Rev Neurol (Paris); 2000 Dec; 156(12):1136-47. PubMed ID: 11139730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strongly succinate dehydrogenase-reactive blood vessels (SSV) in various neuromuscular diseases].
    Matsuoka T; Hasegawa H; Nonaka I
    Rinsho Shinkeigaku; 1992 Jun; 32(6):645-7. PubMed ID: 1424348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MELAS (mitochondrial myopathy, encephalopathy lactic acidosis, and stroke-like episodes): clinical features and mitochondrial DNA mutations].
    Goto Y
    Nihon Rinsho; 1993 Sep; 51(9):2373-8. PubMed ID: 8411715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteroplasmic mitochondrial DNA mutation in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes.
    Chiang LM; Jong YJ; Huang SC; Tsai JL; Pang CY; Lee HC; Wei YH
    J Formos Med Assoc; 1995; 94(1-2):42-7. PubMed ID: 7613232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of complex I genes in MELAS: a novel heteroplasmic mutation 3380G>A in ND1 of mtDNA.
    Horváth R; Reilmann R; Holinski-Feder E; Ringelstein EB; Klopstock T
    Neuromuscul Disord; 2008 Jul; 18(7):553-6. PubMed ID: 18590963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mitochondrial tRNA(Leu)(UUR) mutation at 3,256 associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
    Sato W; Hayasaka K; Shoji Y; Takahashi T; Takada G; Saito M; Fukawa O; Wachi E
    Biochem Mol Biol Int; 1994 Aug; 33(6):1055-61. PubMed ID: 7804130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, pathologic and genetic studies on mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes.
    Guo Y; Guo Z; Chen L; Zhang J; Wang W; Liu X; Ren H; Gao S
    Chin Med J (Engl); 1997 Nov; 110(11):851-5. PubMed ID: 9772417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.